4547-57-3,
4-Butoxyphenylacetic acid,
4-n-Butoxyphenylacetic acid,
2-(4-butoxyphenyl)acetic acid,
Benzeneacetic acid, 4-butoxy-,
(4-butoxyphenyl)acetic acid,
Acetic acid, (p-butoxyphenyl)-,
4-Butoxybenzeneacetic acid,
(p-Butoxyphenyl)acetic acid,
(4-Butoxy-phenyl)-acetic acid,
p-Butoxyphenylacetic acid,
EINECS 224-904-1,
BRN 1105534,
4-(n-butoxy)phenylacetic acid,
4-(n-Butoxyphenyl)acetic acid,
KLJMYYFCWBVKEE-UHFFFAOYSA-N,
MFCD00016832,
FR-0122,
W-202802,
PubChem3115,
AC1L2UXU,
AC1Q2XI0,
Cambridge id 5306907,
p - Butoxyphenylacetic acid,
p-(Butoxyphenyl)acetic acid,
(4-n-Butoxyphenyl)acetic acid,
SCHEMBL1285778,
4-(N-Butoxy)phenyl acetic acid,
CTK1D6086,
DTXSID00196518,
HMS1607O11,
KUC110102N,
KS-000010HX,
PAA-0222,
ZINC2022916,
ZX-BK001676,
BBL021194,
SBB007692,
STK893900,
AKOS000210683,
ACM4547573,
Benzeneacetic acid, 4-butoxy- (9CI),
MCULE-3232884876,
VZ29467,
AJ-32797,
CC-20020,
KSC-229-64-1,
LS-11193,
AX8014157,
BB0249015,
DB-051306,
B4742,
BB 0249015,
FT-0604749,
H8294,
ST50320086,
4-Butoxyphenylacetic acid, >=98.0% (HPLC),
AB00079767-01,
547B573,
C-10604,
SR-01000388884,
I01-8273,
SR-01000388884-1,
Bufexamac impurity A, EuropePharmacopoeia (EP) Reference Standard,
CID78304,
C12-H16-O3,
4-10-00-00544 (Beilstein Handbook Reference),